Anti-SIGLEC H 抗体 [ABM2B55]
Anti-SIGLEC H antibody [ABM2B55]
Be the first to review this product! Submit a review
|
(1 Publication)
Rat Monoclonal SIGLEC H antibody. Suitable for WB and reacts with Mouse samples. Cited in 1 publication.
別名を表示する
SIGLEC like protein, Siglech, sialic acid binding Ig like lectin H
- WB
Supplier Data
Western blot - Anti-SIGLEC H antibody [ABM2B55] (AB228448)
All lanes:
Western blot - Anti-SIGLEC H antibody [ABM2B55] (ab228448) at 2 µg/mL
All lanes:
Mouse skeletal muscle lysate
Predicted band size: 34 kDa
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
精製に関する特記事項
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein plays an important role in the immune response. SIGLEC H functions in the recognition and uptake of pathogens through endocytosis by binding sialylated glycoproteins. Unlike some other members of the SIGLEC family it is not part of a complex and relies on interactions with other signaling molecules. These interactions facilitate phagocytosis and antigen presentation which are critical functions of pDCs in adaptive immunity.
Pathways
SIGLEC H becomes involved in the innate immune signaling pathways that regulate type I interferon production. The pathways include the Toll-like receptor (TLR) signaling pathway. SIGLEC H modulates TLR7 and TLR9 pathways in pDCs which manage the production of cytokines and chemokines. It can also influence the expression of interferon regulatory factors further impacting cytokine production and modulating immune response.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (1)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in oncology 11:683582 PubMed34222004
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com